| Product Code: ETC7656995 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neuroscience Antibodies & Assays Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neuroscience Antibodies & Assays Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neuroscience Antibodies & Assays Market - Industry Life Cycle |
3.4 Israel Neuroscience Antibodies & Assays Market - Porter's Five Forces |
3.5 Israel Neuroscience Antibodies & Assays Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Neuroscience Antibodies & Assays Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Israel Neuroscience Antibodies & Assays Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Neuroscience Antibodies & Assays Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Israel |
4.2.2 Growing investment in neuroscience research and development |
4.2.3 Technological advancements in antibody and assay development for neuroscience applications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for antibody and assay approvals |
4.3.2 Limited availability of skilled professionals in neuroscience research |
4.3.3 High cost associated with development and commercialization of neuroscience antibodies and assays |
5 Israel Neuroscience Antibodies & Assays Market Trends |
6 Israel Neuroscience Antibodies & Assays Market, By Types |
6.1 Israel Neuroscience Antibodies & Assays Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Neuroscience Antibodies & Assays Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Neuroscience Antibodies & Assays Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 Israel Neuroscience Antibodies & Assays Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2 Israel Neuroscience Antibodies & Assays Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Israel Neuroscience Antibodies & Assays Market Revenues & Volume, By Immunoassays/Immunochemistry, 2021- 2031F |
6.2.3 Israel Neuroscience Antibodies & Assays Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.2.4 Israel Neuroscience Antibodies & Assays Market Revenues & Volume, By Other Technologies, 2021- 2031F |
6.3 Israel Neuroscience Antibodies & Assays Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Neuroscience Antibodies & Assays Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.3.3 Israel Neuroscience Antibodies & Assays Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.3.4 Israel Neuroscience Antibodies & Assays Market Revenues & Volume, By Other End Users, 2021- 2031F |
7 Israel Neuroscience Antibodies & Assays Market Import-Export Trade Statistics |
7.1 Israel Neuroscience Antibodies & Assays Market Export to Major Countries |
7.2 Israel Neuroscience Antibodies & Assays Market Imports from Major Countries |
8 Israel Neuroscience Antibodies & Assays Market Key Performance Indicators |
8.1 Number of neuroscience research publications in Israel |
8.2 Investment in neuroscience research and development projects |
8.3 Adoption rate of new neuroscience antibodies and assays technologies in research institutions |
9 Israel Neuroscience Antibodies & Assays Market - Opportunity Assessment |
9.1 Israel Neuroscience Antibodies & Assays Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Neuroscience Antibodies & Assays Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Israel Neuroscience Antibodies & Assays Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Neuroscience Antibodies & Assays Market - Competitive Landscape |
10.1 Israel Neuroscience Antibodies & Assays Market Revenue Share, By Companies, 2024 |
10.2 Israel Neuroscience Antibodies & Assays Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here